ORCHID PHARMABreakout happend in this stock with rising 200dma and RS indicator is also showing strength.
Keep your risk and reward ratios according to your own preferance.
This is for educational purpose, do your own research before investing.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
21.75 INR
921.66 M INR
8.19 B INR
13.37 M
About ORCHID PHARMA LTD
Sector
Industry
CEO
Manish Dhanuka
Website
Headquarters
Narsinghpur
Founded
1992
ISIN
INE191A01027
FIGI
BBG000CX8059
Orchid Pharma Ltd. engages in the provision of development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. Its products include cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, cephalosporins-orals, cephalosporins-injectables, veterinary products, and non-antibiotics. The company was founded by Kailasam Raghavendra Rao on July 1, 1992 and is headquartered in Narsinghpur, India.
Bullish opportunity - Swing trade Double bottom breakout with good volumes. The stock just broken a 20-day high with trading volumes significantly above the 20-day moving average, indicating strong momentum with high market interest.
Cup and handle breakoutGood volume buildup in daily and weekly timeframe.
Cup and Handle breakout with good volume and successfully retest.
Fundamental's are good.
DII stakes increased.
NOTE: I do my analysis, do yours before trade.
ORCHPHARMA Giving a Strong BreakOutOrchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. Its products include cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, cephalosporins-orals, cephalosporins-injectables, veterinary products, an
ORCHPHARMA - Bullish SetupStock name - Orchid Pharma Limited.
Weekly chart setup
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Master Score - C
Disclaimer: This is for demonstration and educ
ORCHID PharmaOrchid pharma: Breakout above 1350, which was its previous high as well.
If we see a breakout with volumes then a fresh spike may come.
One can take at the re test level as well .
Disclaimer: only for education purposes, no buy or sell recommendation. we are not sebi registered. always discus
orchpharma1. Anything can happen.
2. You don't need to know what is going to happen next in order to make money.
3. There is a random distribution between wins and losses for any given set of variables that define an edge. No other thoughts
4. An edge is nothing more than an indication of a higher probability
ORCHID ready to BLOOM?!?!?There's selling pressure from upside!
But the stock seems to have formed a strong base near 950!
A long can be initiated here and buy on dips formula can be applied!
ORCHID
** Adds ORCD is set for strong growth over the next three years as new management continues to execute the turnaround strategy well
** Co leveraging core strengths in key active pharma ingredients (APIs)-like anti-microbials such as Cephalosporin,
** Estimates 35%+ compound annual growth rate (C
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of ORCHPHARMA is 775.30 INR — it has decreased by −0.26% in the past 24 hours. Watch ORCHID PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange ORCHID PHARMA LIMITED stocks are traded under the ticker ORCHPHARMA.
ORCHPHARMA stock has risen by 15.71% compared to the previous week, the month change is a −4.54% fall, over the last year ORCHID PHARMA LIMITED has showed a −27.47% decrease.
We've gathered analysts' opinions on ORCHID PHARMA LIMITED future price: according to them, ORCHPHARMA price has a max estimate of 1,843.00 INR and a min estimate of 1,095.00 INR. Watch ORCHPHARMA chart and read a more detailed ORCHID PHARMA LIMITED stock forecast: see what analysts think of ORCHID PHARMA LIMITED and suggest that you do with its stocks.
ORCHPHARMA reached its all-time high on Jan 3, 2025 with the price of 1,998.00 INR, and its all-time low was 670.05 INR and was reached on Apr 9, 2025. View more price dynamics on ORCHPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ORCHPHARMA stock is 4.76% volatile and has beta coefficient of 1.32. Track ORCHID PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is ORCHID PHARMA LIMITED there?
Today ORCHID PHARMA LIMITED has the market capitalization of 39.32 B, it has increased by 7.10% over the last week.
Yes, you can track ORCHID PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
ORCHID PHARMA LIMITED is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
ORCHPHARMA earnings for the last quarter are 4.25 INR per share, whereas the estimation was 6.30 INR resulting in a −32.54% surprise. The estimated earnings for the next quarter are 4.40 INR per share. See more details about ORCHID PHARMA LIMITED earnings.
ORCHID PHARMA LIMITED revenue for the last quarter amounts to 2.17 B INR, despite the estimated figure of 2.40 B INR. In the next quarter, revenue is expected to reach 2.28 B INR.
ORCHPHARMA net income for the last quarter is 207.75 M INR, while the quarter before that showed 272.37 M INR of net income which accounts for −23.72% change. Track more ORCHID PHARMA LIMITED financial stats to get the full picture.
No, ORCHPHARMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has 923 employees. See our rating of the largest employees — is ORCHID PHARMA LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORCHID PHARMA LIMITED EBITDA is 1.18 B INR, and current EBITDA margin is 13.54%. See more stats in ORCHID PHARMA LIMITED financial statements.
Like other stocks, ORCHPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORCHID PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORCHID PHARMA LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORCHID PHARMA LIMITED stock shows the sell signal. See more of ORCHID PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.